首页> 外文期刊>Environmental microbiology >Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
【24h】

Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis

机译:原发性胆汁性肝硬化患者肠道微生物组,代谢和免疫力的变化及其相关性

获取原文
获取原文并翻译 | 示例
           

摘要

We selected 42 early-stage primary biliary cirrhosis (PBC) patients and 30 healthy controls (HC). Metagenomic sequencing of the 16S rRNA gene was used to characterize the fecal microbiome. UPLC-MS/MS assaying of small molecules was used to characterize the metabolomes of the serum, urine and feces. Liquid chip assaying of serum cytokines was used to characterize the immune profiles. The gut of PBC patients were depleted of some potentially beneficial bacteria, such as Acidobacteria, Lachnobacterium sp., Bacteroides eggerthii and Ruminococcus bromii, but were enriched in some bacterial taxa containing opportunistic pathogens, such as -Proteobacteria, Enterobacteriaceae, Neisseriaceae, Spirochaetaceae, Veillonella, Streptococcus, Klebsiella, Actinobacillus pleuropneumoniae, Anaeroglobus geminatus, Enterobacter asburiae, Haemophilus parainfluenzae, Megasphaera micronuciformis and Paraprevotella clara. Several altered gut bacterial taxa exhibited potential interactions with PBC through their associations with altered metabolism, immunity and liver function indicators, such as those of Klebsiella with IL-2A and Neisseriaceae with urinary indoleacrylate. Many gut bacteria, such as some members of Bacteroides, were altered in their associations with the immunity and metabolism of PBC patients, although their relative abundances were unchanged. Consequently, the gut microbiome is altered and may be critical for the onset or development of PBC by interacting with metabolism and immunity.
机译:我们选择了42例早期原发性胆汁性肝硬化(PBC)患者和30例健康对照(HC)。 16S rRNA基因的元基因组测序被用来表征粪便微生物组。小分子的UPLC-MS / MS分析用于表征血清,尿液和粪便的代谢组。血清细胞因子的液体芯片测定用于表征免疫特征。 PBC患者的肠道中耗尽了一些潜在有益的细菌,例如嗜酸细菌,拉克氏菌,卵形拟杆菌和布鲁米球菌,但富含一些含有机会病原体的细菌类群,例如-变形杆菌,肠杆菌科,奈瑟氏菌,螺旋藻,Veillon ,链球菌,克雷伯菌,胸膜肺炎放线杆菌,双歧厌氧杆菌,白僵菌肠杆菌,副流感嗜血杆菌,微核大球菌和副球菌。几种改变的肠道细菌分类群通过与代谢,免疫和肝功能指标改变相关联而与PBC发生潜在的相互作用,例如克雷伯菌与IL-2A以及奈瑟菌与尿吲哚丙烯酸酯的相互作用。尽管许多肠道细菌(如拟杆菌属的某些成员)的相对丰度并没有改变,但它们与PBC患者的免疫和代谢的关系却发生了改变。因此,肠道微生物组会发生变化,并且可能通过与代谢和免疫相互作用而对PBC的发作或发展至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号